MENU
LABT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Lakewood-Amedex Biotherapeutics (LABT) Ownership - Who owns Lakewood-Amedex Biotherapeutics?

Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others... Show more

Profile

Industry
N/A
Address
8031 Cooper Creek Blvd
Phone
+1 941 225-2515
Employees
N/A
Web
https://lakewoodamedex.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.72M
P/E Ratio
N/A
Total Cash
4.58M
Projected Growth
N/A
Total Debt
101.62K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
1.93
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
LABT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
8031 Cooper Creek Blvd
Phone
+1 941 225-2515
Employees
N/A
Web
https://lakewoodamedex.com
Who owns Lakewood-Amedex Biotherapeutics? LABT symbol Ownership - Tickeron.com